Cite
HARVARD Citation
Le Gall, C. et al. (2022). Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion. Journal for immunotherapy of cancer. 10 (4), p. . [Online].